Literature DB >> 23145961

Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.

Chiara Soldati1, Angela Bithell, Caroline Johnston, Kee-Yew Wong, Lawrence W Stanton, Noel J Buckley.   

Abstract

Huntingtin (Htt) protein interacts with many transcriptional regulators, with widespread disruption to the transcriptome in Huntington's disease (HD) brought about by altered interactions with the mutant Htt (muHtt) protein. Repressor Element-1 Silencing Transcription Factor (REST) is a repressor whose association with Htt in the cytoplasm is disrupted in HD, leading to increased nuclear REST and concomitant repression of several neuronal-specific genes, including brain-derived neurotrophic factor (Bdnf). Here, we explored a wide set of HD dysregulated genes to identify direct REST targets whose expression is altered in a cellular model of HD but that can be rescued by knock-down of REST activity. We found many direct REST target genes encoding proteins important for nervous system development, including a cohort involved in synaptic transmission, at least two of which can be rescued at the protein level by REST knock-down. We also identified several microRNAs (miRNAs) whose aberrant repression is directly mediated by REST, including miR-137, which has not previously been shown to be a direct REST target in mouse. These data provide evidence of the contribution of inappropriate REST-mediated transcriptional repression to the widespread changes in coding and non-coding gene expression in a cellular model of HD that may affect normal neuronal function and survival.
© 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23145961     DOI: 10.1111/jnc.12090

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  33 in total

Review 1.  MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites.

Authors:  Silvia Bicker; Martin Lackinger; Kerstin Weiß; Gerhard Schratt
Journal:  Cell Mol Life Sci       Date:  2014-07-10       Impact factor: 9.261

Review 2.  A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.

Authors:  Kensuke Sakamoto; James J Crowley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-06-14       Impact factor: 3.568

3.  Two-track virtual screening approach to identify both competitive and allosteric inhibitors of human small C-terminal domain phosphatase 1.

Authors:  Hwangseo Park; Hye Seon Lee; Bonsu Ku; Sang-Rae Lee; Seung Jun Kim
Journal:  J Comput Aided Mol Des       Date:  2017-06-26       Impact factor: 3.686

Review 4.  The expanding role for chromatin and transcription in polyglutamine disease.

Authors:  Ryan D Mohan; Susan M Abmayr; Jerry L Workman
Journal:  Curr Opin Genet Dev       Date:  2014-08-11       Impact factor: 5.578

5.  The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma.

Authors:  Amanda Tivnan; Jack Zhao; Terrance G Johns; Bryan W Day; Brett W Stringer; Andrew W Boyd; Sarita Tiwari; Keith M Giles; Charlie Teo; Kerrie L McDonald
Journal:  Tumour Biol       Date:  2013-09-26

Review 6.  Epigenetics and therapeutic targets mediating neuroprotection.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Brain Res       Date:  2015-07-30       Impact factor: 3.252

7.  Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease.

Authors:  Lan Lin; Juw Won Park; Shyam Ramachandran; Yida Zhang; Yu-Ting Tseng; Shihao Shen; Henry J Waldvogel; Maurice A Curtis; Richard L M Faull; Juan C Troncoso; Olga Pletnikova; Christopher A Ross; Beverly L Davidson; Yi Xing
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

8.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

Review 9.  Engineered BDNF producing cells as a potential treatment for neurologic disease.

Authors:  Peter Deng; Johnathon D Anderson; Abigail S Yu; Geralyn Annett; Kyle D Fink; Jan A Nolta
Journal:  Expert Opin Biol Ther       Date:  2016-05-21       Impact factor: 4.388

10.  Small Non-coding RNAs Are Dysregulated in Huntington's Disease Transgenic Mice Independently of the Therapeutic Effects of an Environmental Intervention.

Authors:  Celine Dubois; Geraldine Kong; Harvey Tran; Shanshan Li; Terence Y Pang; Anthony J Hannan; Thibault Renoir
Journal:  Mol Neurobiol       Date:  2021-03-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.